elotuzumab,prednisone,thalidomide,carfilzomib,cyclophosphamide,bortezomib,daratumumab,dexamethasone,pomalidomide,lenalidomide,melphalan
amgen,gsk,janssen,takeda,bms
['d-rvd', 'cassiopeia', 'lenalidomide', 'melphalan', 'borte', 'dexamethasone', 'krd', 'daratumumab', 'determination', 'mmsm', 'ifm,2009,2', 'elotuzumab', 'prednisone', 'cyclophosphamide', 'bortezomib', ' lena', 'thalidomide', 'griffin', 'd-vmp']
#ash22 #mmsm education session summary of rct for induction ttt for transplant-eligible ndmm 
Assistant professor @UAMSMyeloma. Alumni heme/onc @bcmhouston, clinical research/biostat @UMich.Focus on plasma cell disorders & health disparities